General
Preferred name
VORTIOXETINE HYDROBROMIDE
Synonyms
Lu AA21004 hydrobromide ()
Vortioxetine (Lu AA21004) HBr ()
Vortioxetine HBr ()
Vortioxetine (hydrobromide) ()
Lu AA21004 (hydrobromide) ()
Lu AA21004 (HBr) ()
Trintellix ()
Lu-aa21004 hydrobromide ()
Lu aa21004 hbr ()
P&D ID
PD000130
CAS
960203-27-4
Tags
available
drug
Drug Status
approved
Max Phase
Phase 4
First approval
2013
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
7
AdooQ Bioactive Compound Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
MedChem Express Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
15
Properties
(calculated by RDKit )
Molecular Weight
378.08
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
1
Rotatable Bonds
3
Ring Count
3
Aromatic Ring Count
2
cLogP
4.44
TPSA
15.27
Fraction CSP3
0.33
Chiral centers
0.0
Largest ring
6.0
QED
0.85
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Pathway
GPCR/G protein
Neuroscience
Neuronal Signaling
Target
5-HT1A
5-HT1B
5-HT3A
5-HT7
SERT
5-HT Receptor
Serotonin Transporter
Source data
